Increasing world incidence of thyroid cancer: Increased detection or higher radiation exposure?

Hormones

Volumn 9, Issue 2, 2010, Pages 103-108

  Wartofsky, Leonard ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Follicular thyroid adenoma; Follicular thyroid carcinoma; Irradiation; Thyroid cancer

Indexed keywords

IODINE;

ASPIRATION BIOPSY; CANCER INCIDENCE; CANCER RISK; CHERNOBYL ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DIETARY INTAKE; DOPPLER ECHOGRAPHY; EPIDEMIC; ETHNIC DIFFERENCE; EXTERNAL BEAM RADIOTHERAPY; FALLOUT; GEOGRAPHY; HEAD AND NECK CANCER; HUMAN; IODINE DEFICIENCY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PROGNOSIS; RADIATION EXPOSURE; REVIEW; RISK FACTOR; SEX DIFFERENCE; THYROID CANCER; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

EID: 77953203968     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1260     Document Type: Review

References (50)

1. Davies L, Welch HG, 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295: 2164-2167.
2. Jemal A, Siegel R, Ward E, et al, 2006 Cancer Statistics, CA Cancer J Clin 56: 106-130.
3. Ito J, Noguchi S, Murakami T, Noguchi A, 1980 F actors affecting the prognosis of patients with carcinoma of the thyroid. Surg Gynecol Obstet 150: 539-544.
4. Kesmodel SB, Terhune KP, Canter RJ, et al, 2003 The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. Surgery 134: 1005-1012.
5. Ain K B, 1995 Papillary thyroid carcinoma. Etiology, assessment, and therapy. Endocrinol Metab Clin North Am 24: 711-760.
6. Schlumberger MJ, 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338: 297-306.
7. Robbins J, Merino MJ, Boice JD Jr, et al, 1991 Thyroid cancer: a lethal endocrine neoplasm. Ann Intern Med 115: 133-147.
8. Hay ID, 1990 Papillary thyroid carcinoma. Endocrinol Metab Clin North A m 19: 545-576.
9. Kashima K, Yokoyama S, Noguchi S, et al, 1998 Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 8: 197-202.
10. Loh K C, Greenspan FS, Dong F, Miller TR, Yeo PP, 1999 Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84: 458-463.
11. Mechler C, Bounacer A, Suarez H, et al, 2001 Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring R ET/PTC rearrangements. Br J Cancer 85: 1831-1837.
12. Uchino S, Noguchi S, Kawamoto H, et al, 2002 Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg 26: 897-902.
13. Larson SD, Jackson LN, Riall TS, et al, 2007 Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg 204: 764-775.
14. Pal T, Vogl FD, Chappuis PO, et al, 2001 Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 86: 5307-5312.
15. Chen AY, Levy L, Goepfert H, Brown BW, Spitz MR, Vassilopoulou-Sellin R, 2001 T he development of breast carcinoma in women with thyroid carcinoma. Cancer 92: 225-231.
16. Garner CN, Ganetzky R, Brainard J, et al, 2007 Increased prevalence of breast cancer among patients with thyroid and parathyroid disease. Surgery 142: 806-813.
17. Polednak A P, 1994 T rends in cancer incidence in Connecticut 1935-1991. Cancer 74: 2863-2872.
18. Goodman MT, Yoshizawa CN, Kolonel LN, 1988 Descriptive epidemiology of thyroid cancer in Hawaii. Cancer 61: 1272-1281.
19. Whelan SL, Parkin DM, Masuyer E, 1990 Patterns of cancer in five continents. IARC Sci Publ 102: 1-159.
20. Ferlay J, Bray F, Pisani P, Parkin DM 2004 Globocan 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, Lyon: IARC Press.
21. Franceschi S, LaVecchia C, Bidoli E, 1998 High incidence of thyroid cancer in central Italy. Int J Cancer 77: 481-482.
22. Hrafnkelsson J, Jonasson JG, Sigurdsson G, Sigvaldason H, Tulinius H, 1988 T hyroid cancer in Iceland 1955-1984. Acta Endocrinol (Copenh) 118: 566-572.
23. Liu S, Semenciw R, Ugnat A M, Mao Y, 2001 Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. Br J Cancer 85: 1335-1339.
24. Hodgson NC, Button J, Solorzano CC, 2004 Thyroid cancer: is the incidence still increasing? Ann Surg Oncol 11: 1093-1097.
25. Burgess JR, 2002 Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982-1987). Thyroid 12: 141-149.
26. Truong T, Rougier Y, Dubourdieu, et al, 2007 Time trends and geographic variations for thyroid cancer in New Caledonia, a very high incidence area (1985-1999). Eur J Cancer Prev 16: 62-70.
27. Colonna M, Grosclaude P, Remontet L, et al, 2002 Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). Europ J Cancer 38: 1762-1768.
28. Reynolds R M, Weir J, Stockton DL, Brewster DH, Sandeep T C, Strachan MW, 2005 Changing trends in incidence and mortality of thyroid cancer in S cotland. Clin Endocrinol (Oxf) 62: 156-162.
29. Dijkstra B, Prichard RS, Lee A, et al, 2007 Changing patterns of thyroid carcinoma. Irish J Med Sci 176: 87-90.
30. Cardis E, Kesminierne A, Ivanov V, et al, 2005 Risk of thyroid cancer after exposure to 131-I in childhood. J Natl Cancer Inst 97: 724-732.
31. Figge JJ, Jennings T, Gerasimov G, Kartel N, Yarmolinsky D, Ermak G, 2006 Radiation induced thyroid cancer. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Eds), Humana Press, T otowa, NJ; pp, 63-83.
32. Jacob P, Kenigsberg Y, Zvonova I, et al, 1999 Childhood exposure due to the Chernobyl accident and thyroid cancer risk in contaminated areas of Belarus and Russia. Br J Cancer 80: 1461-1469.
33. Kerber RA, Till JE, Simon S L, et al, 1993 A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. JAMA 270: 2076-2082.
34. Conard RA, Dobyns BM, Sutow WW, 1970 Thyroid neoplasia as late effect of exposure to radioactive iodine in fallout. JAMA 214: 316-324.
35. Parker N, Belsky JL, Yamamoto T, Kawamoto S, Keehn RJ, 1974 Thyroid carcinoma after exposure to atomic radiation: a continuing survey of a fixed population, Hiroshima and Nagasaki, 1958-1971. Ann Intern Med 80: 600-604.
36. Imaizumi M, Usa T, Tominaga T, et al, 2006 Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure. JAMA 295: 1011-1022.
37. Davis S, Kopecky K J, Hamilton T E, Onstad L, Hanford Thyroid Disease Study Team, 2004 Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the Hanford nuclear site. JAMA 292: 2600-2613.
38. Hahn K, Schnell-Inderst P, Grosche B, Holm LE, 2001 Thyroid cancer after diagnostic administration of iodine-131 in childhood. Radiat Res 156: 61-70.
39. Dickman PW, Holm LE, Lundell G, Boice JD Jr, Hall P, 2003 Thyroid cancer risk after thyroid examination with 131-I: a population-based cohort study in Sweden. Int J Cancer 106: 580- 587.
40. Holm LE, Hall P, Wiklund K, et al, 1991 Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 83: 1072-1077.
41. Sarne D, Schneider A B, External radiation and thyroid neoplasia. Endocrinol Metab Clin North Am 25: 181-196.
42. Ron E, Kleinerman RA, Boice JD Jr, LiVolsi VA, Flannery JT, Fraumeni JF Jr, 1987 A population-based case-control study of thyroid cancer, J Natl Cancer Inst 79: 1-12.
43. Favus MJ, Schneider A B, Stachura ME, et al, 1976 Thyroid cancer occurring as a late consequence of head-and-neck irradiation: Evaluation of 1056 patients. N Engl J Med 294: 1019-1025.
44. Mellemgaard A, From G, Jorgensen T, Johansen C, Olsen JH, Perrild H, 1998 Cancer risk in individuals with benign thyroid disorders. Thyroid 8: 751-754.
45. Herraiz M, Barbesino G, Gaquin W, et al, 2007 Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. Clin Gastroenterol Hepatol 5: 367-373.
46. Kent L, McBride R, McConnell R, Neugut A I, Bhagat G, Green PH, 2006 Increased risk of papillary thyroid cancer in celiac disease. Dig Dis Sci 51: 1875-1877.
47. Guignard R, Truong T, Rougier Y, Baron-Dubourdieu D, Guenel P, 2007 A lcohol drinking tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia. A m J Epidemiol 166: 1140-1149.
48. Hovens GC, S tokkel MP, K ievit J, et al, 2007 A ssociations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer. J Clin Endocrinol Metab 92: 2610-2615.
49. Boelaert K, Horacek J, Holder R L, Watkinson JC, Sheppard MC, Franklyn JA, 2006 Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle-aspiration. J Clin Endocrinol Metab 91: 4295-4301.
50. Haymart MR, Repplinger DJ, Leverson GE, et al, 2007 Higher serum TS H level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 93: 809-814.